ICD-116A06	STEREOTYPED MOVEMENT DISORDER Stereotyped movement disorder
ICD-10F98.4	Stereotyped movement disorders
DSM-5-TRF98.4	Stereotypic Movement Disorder

1. Definition and nosology

Stereotyped movement disorder (ICD-11: 6A06 Stereotyped Movement Disorder; DSM-5-TR: F98.4 Stereotypic Movement Disorder) — characterized by seemingly voluntary, repetitive, rhythmic, purposeless motor behavior, interfering with daily activity or causing bodily injury, a neurodevelopmental disorder. Typical examples: hand flapping, body rocking, head banging, hair pulling, lip biting, finger knuckle play.

The disorder is classified into two forms:

• Primary (primary, idiopathic) — In a child with normal IQ, without other neurodevelopmental or somatic disorder;
• Secondary — Intellectual disability, autism spectrum disorder, sensory deprivation (visual/hearing impairment) or against a medical condition background.

DSM-5-TR — with severity specifier — Non-suicidal self-injury or without it.

2. History

• Kanner L. (1943) — In the description of autism, stereotyped behaviors are noted as the restricted-repetitive behaviors category.
• 1960s–1970s — Stereotypy descriptions in institutional populations regarding intellectual disability.
• DSM-III-R (1987) — Stereotypy/Habit Disorder as a separate category.
• Mahone E.M. et al. J Child Neurol 2004, 2014 — systematically described the syndrome of “primary complex motor stereotypies” in children with intact cognitive development; prior to this work, such children were often misdiagnosed as autism spectrum disorder.
• DSM-5 (2013) and ICD-11 (2019) — included in the category of neurodevelopmental disorders; add self-harm qualifier.

3. Epidemiology

• Transient stereotypies observed in 3–15% of healthy children up to 3 years of age (Foster L.G. J Dev Behav Pediatr 1998).
• Primary clinical stereotypic movement disorder — approximately 3–4% in children with normal cognitive development (Freeman R.D. et al. Mov Disord 2010).
• Secondary forms — Up to 60% in intellectual disability; ~80% of patients with severe and profound intellectual disability have some form of stereotypy; almost always present in some form in autism spectrum disorder (Bodfish J.W. et al. J Autism Dev Disord 2000).
• Sex: in initial forms, males 3:1; in secondary forms difference smaller.
• Age of onset: typically up to age 3 (DSM-5-TR criterion).
• Self-harm (self-injurious behavior, SIB): rare in the general population, but occurs in 25–30% of severe intellectual disability, and almost always in syndromes such as Lesch-Nyhan or Cornelia de Lange.

4. Aetiology and pathogenesis

4.1 Neurobiological mechanisms

• Basal ganglia and cortex-striatum circuit dysfunction — Habit selection and motor inhibition process impairment (Singer H.S. Semin Pediatr Neurol 2009).
• Dopaminergic system — D1 and D2 receptor imbalance; dopamine agonists enhance stereotyped behavior in experimental models.
• Serotonergic system — Some patients show partial response to SSRI.
• Opioid system — self-harm forms under endogenous opioid dysregulation hypothesis (naltrexone shows partial effect).

4.2 Genetic and family factors

• In primary stereotypy, familial clustering is noted — family history 25–30% (Mahone 2014).
• Stereotypy is highly prevalent in specific genetic syndromes — Rett (MECP2), Lesch-Nyhan (HPRT1), Cornelia de Lange (NIPBL), Smith-Magenis (RAI1), Fragile X (FMR1), Phelan-McDermid (22q13).

4.3 Environmental and behavioral factors

• Sensory deprivation — Institutional environment, high frequency in blind or deaf children.
• Behavioral mechanisms — self-stimulation (sensory input seeking), automatic reinforcement (intrinsic reinforcement), context-dependent functional connection (avoidance, attention).
• Stress and anxiety disorders may intensify stereotypic severity.

5. Clinical features

5.1 Typical motor patterns

• Hand flapping — most frequent; during emotional excitement or concentration.
• Body rocking — sitting or standing.
• Head banging — a form of self-harm; against a pillow, wall or floor.
• Body hugging, finger tapping, lip biting, hair pulling.
• Visual stimulation — Hand-waving before eyes, gazing at light.
• Self-injurious behavior (SIB) — Head banging, biting, hitting, self-injury with teeth.

5.2 Clinical features

• Duration — from seconds to hours; 5–10 minutes per episode typical.
• Triggers — Excitement (pleasant or stressful), concentration, inactivity (free time).
• Attention termination — behavior stops when patient is called or redirected to another activity (unlike tics — no premonitory urge).
• Functional role of stereotypy — self-stimulation, calming, sensory stimulation management.

5.3 Comorbidity

• Intellectual disability (in secondary forms).
• Autism spectrum disorder (comorbid 30–50% in primary stereotypy — Mahone 2014).
• ADHD — comorbid in 20–35% of children with primary stereotypies.
• Anxiety and OCD-like symptoms.
• Tic disorders — differentiation may be difficult.

6. Diagnosis

6.1 Unified diagnostic criteria (DSM-5-TR · ICD-11 consensus points)

A. Repetitive, non-goal-directed, apparently voluntary motor behavior (e.g., hand flapping, body rocking, head banging, self-biting).

B. The behavior interferes with social, academic, or other activities or leads to self-harm.

C. Onset in early developmental period (typically by age 3).

D. Not fully explained by a substance (e.g., stimulant) or neurological condition (tic, choreoathetosis, dystonia, dermatillomania, trichotillomania); not better explained by OCD, ASD, or another mental disorder (comorbidity not excluded).

6.2 Source-specific clarifications

• DSM-5-TR (F98.4): severity qualifier — with / without self-harm; additional qualifiers — with known medical/genetic condition; on the background of intellectual disability or autism.
• ICD-11 (6A06): Parallel structure; emphasis on ‘non-purposeful repetitive motor behavior’.
• Mahone E.M. et al. J Child Neurol 2014: “Primary Complex Motor Stereotypies” (PCMS) — attention to a distinct clinical form in children with normal cognitive development; typical hand/arm stereotypies; risk of being confused with autism.

6.3 Diagnostic algorithm

1. Parent interview and video documentation (family-recorded episodes via phone are diagnostically valuable).
2. Developmental and neurological examination.
3. Tics and other movement disorders (chorea, myoclonus, dystonia) differential diagnosis — neurologist consultation.
4. Comorbidity screening — autism spectrum (M-CHAT-R/F, ADOS-2), intellectual disability (Vineland-3, IQ), ADHD, anxiety.
5. Excluding sensory impairment — hearing and vision test.
6. If self-harm exists — functional behavior assessment (FBA).
7. Specific clinical suspicion based on — genetic testing (CMA, FMR1, MECP2, Lesch-Nyhan HPRT activity and uric acid).

6.4 Differential diagnosis

7. Examination and assessment

7.1 Clinical interview and scales

• Stereotypy Severity Scale (SSS) — Miller J.M., Singer H.S. et al.
• Repetitive Behavior Scale-Revised (RBS-R) — in comorbid cases of autism and intellectual disabilities.
• Video recordings — home episode logs conducted by family assessed by clinician.
• Functional behavior analysis (FBA) — for intervention planning in self-harm or context-dependent stereotypy.

7.2 Laboratory investigations

No routine indication. Based on clinical suspicion:

• Genetic panel (CMA, Fragile X) — if intellectual disability or syndromic features present.
• MECP2 (Rett in girls).
• HPRT activity and uric acid — suspected Lesch-Nyhan syndrome (self-biting).
• Thyroid, lead levels.
• Toxicology screening — in adolescents.

7.3 Instrumental investigations

• EEG — if seizure is suspected.
• Brain MRI — focal neurological signs or regression.
• Hearing and vision test — to assess the role of sensory deprivation.

8. Treatment

8.1 General principles

1. Behavioral intervention first-line — individualized plan based on functional behavior analysis.
2. In primary stereotypy — if the patient does not experience functional difficulty, observation may suffice. (Mahone 2014). Explanation of nature and prognosis to the family; no mandatory intervention required.
3. When functional difficulty or interference with social functioning is present — HRT (Habit Reversal Training), DRO (Differential Reinforcement of Other behavior), RIRD (Response Interruption and Redirection) evidence-based behavioral interventions.
4. In self-injurious behavior — Multidisciplinary approach; behavioral interventions + protective devices (padded helmet) + pharmacotherapy (in refractory cases).
5. Sensory deprivation — enrichment of the environment (toys, social interaction), alternative activities providing sensory input to the patient.
6. Comorbidity treatment — Autism, intellectual disability, ADHD, anxiety.
7. Pharmacotherapy has limited evidence base — only in severe cases, unresponsive to behavioral intervention; self-harm or in comorbid context of autism/intellectual disability.

8.2 Pharmacotherapy (Limited Evidence)

• Atypical antipsychotic (risperidone, aripiprazole) — For behavioral aggression and self-harm on the background of autism/intellectual disability; FDA approval — risperidone 5–16 years ASD irritability (including self-harm), aripiprazole 6–17 years ASD irritability. No FDA-approved medication for “core” symptoms of stereotypic movement disorder.
• SSRIs — fluoxetine, sertraline – show modest effect in some patients, especially in comorbid anxiety cases; evidence base limited.
• Naltrexone — considered in self-injurious behaviour (based on the endogenous opioid hypothesis); RCT evidence limited, Symons F.J. et al. Am J Ment Retard 2004 review — small effect size.
• Clonidine, guanfacine — It may help in comorbid ADHD or sleep disorder.

8.3 Special Conditions

• Self-harm (SIB): emergency behavioral analysis; protective measures (helmet, without arm restraints) short-term; intensive behavioral intervention; pharmacotherapy for refractory cases; hospitalization in severe cases.
• Specific genetic syndromes — Self-biting in Lesch-Nyhan almost always present; oral-dental compromise (dental extraction last resort); allopurinol for metabolic condition.
• Sensory deprivation — Environmental change, alternative sensory input.

8.4 Source-Specific Clarifications

• Mahone E.M. et al. J Child Neurol 2014: in initial forms, aggressive intervention not required; explanation of prognosis and nature to family; HRT effective in adolescence.
• AAP — self-harm protocol: in children with intellectual disability multimodal approach.
• NICE NG11 (Challenging Behaviour and Learning Disabilities, 2015): in intellectual disability behavioral intervention first line; antipsychotic only in refractory cases and short-term.

Treatment methods

1. Habit Reversal Training (HRT — Habit Reversal Training) — Azrin (Azrin N.H.), Nunn (Nunn R.G.) — Five core components — awareness training (behavioral recognition), competing response training, motivational component, social support, generalization training. Evidence-based in stereotypic movement disorder and tic disorders. Evidence: Specht M.W. et al. J Child Neurol 2017 RCT — reduction in severity in primary complex motor stereotypies.
2. Differential Reinforcement of Other Behavior (DRO) — Positive reinforcement (token, praise, activity) of time intervals without stereotypies. Effective in intellectual disability context. A core component of ABA.
3. Response Interruption and Redirection (RIRD) — Interruption when stereotypic behavior begins and redirecting to an alternative engaging task. Used for vocal stereotypies and severe cases. Ahearn W.H. et al. J Appl Behav Anal 2007.
4. Functional Behavior Assessment (FBA) — Systematic analysis of behavior antecedent (precondition), functional consequence, and context — basis for individualizing intervention plan. Within ABA and PBS.
5. Stereotypy Severity Scale (SSS) — Miller (Miller J.M.), Singer (Singer H.S.) — Standardized assessment of stereotypy frequency, duration, intensity, and interference level.
6. Repetitive Behavior Scale-Revised (RBS-R — Repetitive Behavior Scale-Revised) — Bodfish (Bodfish J.W.) et al — 43-item parent questionnaire – stereotyping, self-harm, compulsive, ritualized, insistence on sameness, restricted behavior subscales. Used in comorbid autism and intellectual disability cases.

9. Prognosis

Good prognostic factors

• Primary form, normal IQ.
• No self-harm.
• Early HRT intervention response.
• Absence of comorbidity.
• Family support and realistic expectations.

Poor prognostic factors

• Secondary form — within the context of severe intellectual disability or genetic syndrome.
• Self-injurious behavior — especially in Lesch-Nyhan, Cornelia de Lange.
• Comorbid autism spectrum disorder.
• Non-response to behavioral intervention.

Follow-up targets

• Frequency, duration, intensity of stereotypy (SSS) — 3–6 months.
• Functional impairment and self-harm monitoring.
• Comorbidity (autism, ADHD, anxiety, OCD) screening.
• Social adjustment support in adolescence and adulthood.
• In those receiving pharmacotherapy — monitoring for side effects (metabolic, EPS).

10. Myths and misconceptions

10.1 Aetiology myths

Myth 1: “Stereotypy is always a sign of autism”

Why it is widespread: Stereotypies are included in DSM-5 autism criteria and primarily associated with autism in mass media.

Clinical and biological rationale: Mahone E.M. et al. J Child Neurol 2004, 2014 — “Primary Complex Motor Stereotypies” the syndrome can also occur in children with normal cognitive development without social reciprocal interaction deficit or restricted-repetitive behavior pattern. 30–50% of these children may have comorbid autism or ADHD, but most do not.

Evidence: Mahone 2014; Freeman R.D. et al. Mov Disord 2010 — primary stereotypy is a distinct clinical entity from autism.

Real clinical step: each child with stereotypical behavior should be separately evaluated for autism spectrum as differential; if no comorbidity, family should not be alarmed.

Myth 2: “Stereotypy is a result of poor upbringing or emotional deprivation”

Why it is widespread: In the 1960s, observations of high prevalence in institutionalized children strengthened the ‘deprivation’ theory.

Evidence: Bodfish J.W. et al. J Autism Dev Disord 2000 — stereotypy is a neurobiologically based disorder, with dysfunction of the basal ganglia and cortex-striatum circuit. Sensory deprivation can affect severity, but is not etiology. It is also observed in children growing up in healthy, supportive families.

Myth 3: “The child will outgrow it with age — no action is needed”

Evidence: Transient childhood stereotypies resolve by age 3; however primary clinical stereotypy Typically progresses — Mahone 2014 follow-up studies have documented this up to adulthood. The family should be provided with a realistic prognosis; intervention is required if self-harm or functional impairment exists.

10.2 Harmful or erroneous methods

Myth 4: “Physical restraint of a child (tying arms, stopping movement) resolves stereotypies”

Why it is widespread: intuitively, behavioral “holding” symptom appears to eliminate.

Clinical logic and evidence: Continuous physical restraint is counterproductive — increases patient distress, impairs autonomy, causes skin injury and contractures. NICE NG11 (2015), AAP — restraint only for urgent and short-term self-harm situations for protective purposes; not recommended as continuous treatment. Functional behavioral analysis-based positive behavioral intervention (PBS) superior.

Myth 5: “Punishment (sharp redirection, scolding, physical punishment) resolves stereotypy”

Evidence: NICE NG11 — punishment-based approach is not effective in reducing behavior; creates risk of emotional harm and trauma. ABA practice in modern form is based on positive reinforcement (DRO) instead of punishment.

Myth 6: “Antipsychotics are effective for all stereotypic movements”

Evidence: Antipsychotics (risperidone, aripiprazole) FDA-approved for irritability in ASD — including self-harm. No FDA approval for initial stereotypy; effect on ‘core’ stereotypy limited. Side effect burden (metabolic, EPS, prolactin) significant. NICE NG11 — antipsychotic only for refractory severe behavior and short-term.

10.3 Ineffective or scientifically unfounded methods

Myth 7: Sensory integration therapy (Ayres SI) cures stereotypy

Evidence: AAP 2012 Sensory Integration Statement — therapeutic effect classified as ‘research ongoing’; specific effect evidence for stereotypical behavior is weak. Functional behavioral intervention (HRT, DRO) is superior in evidence.

Myth 8: Hyperbaric oxygen chamber, stem cell injections, chelation resolve stereotypy

Evidence: Cochrane and FDA warnings (same position in the context of autism) — these interventions have no effect on stereotypy or neurodevelopmental disorder, and the risk profile is significant.

Myth 9: “Special diet (gluten-free, casein-free) eliminates stereotypies”

Evidence: Hyman S.L. et al. AAP 2020 — effect of special diet for stereotypy or autism not proven.

Myth 10: “EEG Neurofeedback resolves stereotypies”

Evidence: No evidence base for neurofeedback in stereotypical movement disorder. Mild effect in ADHD, but extrapolation to stereotypical behavior is unfounded.

Myth 11: “Homeopathy, acupuncture, craniosacral therapy”

Evidence: none have proven efficacy for stereotypical movement disorder.

11. Sources

1. WHO. ICD-11 for Mortality and Morbidity Statistics. 6A06 Stereotyped movement disorder. 2024.
2. American Psychiatric Association. DSM-5-TR. Washington DC: APA Publishing; 2022.
3. Mahone E.M., Bridges D., Prahme C., Singer H.S. Repetitive arm and hand movements (complex motor stereotypies) in children. J Child Neurol 2004;19(5):379–383.
4. Singer H.S. Motor stereotypies. Semin Pediatr Neurol 2009;16(2):77–81.
5. Freeman R.D., Soltanifar A., Baer S. Stereotypic movement disorder: easily missed. Dev Med Child Neurol 2010;52(8):733–738.
6. Bodfish J.W., Symons F.J., Parker D.E., Lewis M.H. Varieties of repetitive behavior in autism: comparisons to mental retardation. J Autism Dev Disord 2000;30(3):237–243.
7. Specht M.W., Mahone E.M., Kline T. et al. Efficacy of parent-delivered behavioral therapy for primary complex motor stereotypies. J Child Neurol 2017;32(2):204–212.
8. NICE Guideline NG11. Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges. 2015.
9. Symons F.J., Thompson A., Rodriguez M.C. Self-injurious behavior and the efficacy of naltrexone treatment: a quantitative synthesis. Ment Retard Dev Disabil Res Rev 2004;10(3):193–200.
10. Ahearn W.H., Clark K.M., MacDonald R.P., Chung B.I. Assessing and treating vocal stereotypy in children with autism. J Appl Behav Anal 2007;40(2):263–275.
11. Foster L.G. Nervous habits and stereotyped behaviors in preschool children. J Am Acad Child Adolesc Psychiatry 1998;37(7):711–717.
12. Hyman S.L., Levy S.E., Myers S.M.; AAP Council on Children with Disabilities. Identification, Evaluation, and Management of Children With Autism Spectrum Disorder. Pediatrics 2020;145(1):e20193447.
13. Azrin N.H., Nunn R.G. Habit-reversal: a method of eliminating nervous habits and tics. Behav Res Ther 1973;11(4):619–628.
14. Miller J.M., Singer H.S., Bridges D.D., Waranch H.R. Behavioral therapy for treatment of stereotypic movements in nonautistic children. J Child Neurol 2006;21(2):119–125.